Suppr超能文献

采用药无花果胶制备咪达唑仑粘膜黏附型原位鼻腔凝胶的研制与评价。

Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.

机构信息

Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.

出版信息

AAPS PharmSciTech. 2010 Sep;11(3):1223-31. doi: 10.1208/s12249-010-9477-x. Epub 2010 Aug 4.

Abstract

The objective of the present study was to prepare mucoadhesive in situ nasal gels with mucilage isolated from fig fruits (Ficus carica, family: Moraceae) containing midazolam hydrochloride. Nasal gels of midazolam were prepared using three different concentrations (0.5%, 1.0% and 1.5% w/v) of F. carica mucilage (FCM) and synthetic polymers (hydroxypropylmethyl cellulose and Carbopol 934). Evaluation of FCM showed that it was as safe as the synthetic polymers for nasal administration. In situ gels were prepared with mixture Pluronic F127 and mucoadhesive agents. Evaluation of the prepared gels was carried out, including determination of viscosity, texture profile analysis and mucoadhesive strength. In vitro drug permeation study was conducted with the gels prepared with and without permeation enhancer (0.5% w/v sodium taurocholate) using excised goat nasal mucosa. In vitro permeation profiles were evaluated, and histological study of nasal mucosae before and after permeation study was also conducted to determine histological change, if any. In vivo experiments conducted in rabbits further confirmed that in situ nasal gels provided better bioavailability of midazolam than the gels prepared from synthetic mucoadhesive polymers. It was observed that the nasal gel containing 0.5% FCM and 0.5% sodium taurocholate exhibited appropriate rheological, mechanical and mucoadhesive properties and showed better drug release profiles. Moreover, this formulation produced no damage to the nasal mucosa that was used for the permeation study, and absolute bioavailability was also higher compared to gels prepared from synthetic polymers.

摘要

本研究的目的是制备含有盐酸咪达唑仑的具有粘弹性的原位鼻腔凝胶,其粘弹性来自于无花果树(榕属,桑科)的粘胶。使用三种不同浓度(0.5%、1.0%和 1.5%w/v)的无花果树粘胶(FCM)和合成聚合物(羟丙基甲基纤维素和卡波姆 934)制备咪达唑仑鼻用凝胶。对 FCM 的评估表明,它与合成聚合物一样安全,可用于鼻腔给药。原位凝胶是用混合物 Pluronic F127 和粘膜粘附剂制备的。对所制备的凝胶进行了评价,包括粘度测定、质地分析和粘膜粘附强度。通过使用含有和不含有渗透增强剂(0.5%w/v 牛磺胆酸钠)的凝胶进行体外药物渗透研究,使用离体山羊鼻黏膜。评价了体外渗透曲线,并对渗透研究前后的鼻黏膜进行了组织学研究,以确定是否有任何组织学变化。在兔子中的体内实验进一步证实,与由合成粘膜粘附聚合物制备的凝胶相比,原位鼻腔凝胶提供了更好的咪达唑仑生物利用度。观察到含有 0.5%FCM 和 0.5%牛磺胆酸钠的鼻腔凝胶表现出适当的流变学、机械和粘膜粘附性能,并显示出更好的药物释放曲线。此外,与由合成聚合物制备的凝胶相比,该制剂对用于渗透研究的鼻黏膜没有造成损伤,并且绝对生物利用度也更高。

相似文献

1
Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.
AAPS PharmSciTech. 2010 Sep;11(3):1223-31. doi: 10.1208/s12249-010-9477-x. Epub 2010 Aug 4.
7
Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.
Int J Nanomedicine. 2012;7:1373-85. doi: 10.2147/IJN.S28261. Epub 2012 Mar 12.
8
Mucoadhesive polymeric hydrogels for nasal delivery of acyclovir.
Drug Dev Ind Pharm. 2009 Mar;35(3):352-62. doi: 10.1080/03639040802360510.
9
Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
AAPS PharmSciTech. 2017 Oct;18(7):2673-2682. doi: 10.1208/s12249-017-0747-8. Epub 2017 Mar 9.

引用本文的文献

4
Unravelling Micro and Nano vesicular System in Intranasal Drug Delivery for Epilepsy.
Pharm Nanotechnol. 2022 Apr 26. doi: 10.2174/2211738510666220426115340.
6
Intranasal delivery of Clozapine using nanoemulsion-based gels: An approach for bioavailability enhancement.
Saudi Pharm J. 2021 Dec;29(12):1466-1485. doi: 10.1016/j.jsps.2021.11.006. Epub 2021 Nov 15.
8
Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.
AAPS PharmSciTech. 2021 May 4;22(4):147. doi: 10.1208/s12249-021-02020-y.
9
Development of Moxifloxacin Hydrochloride loaded gel for the treatment of periodontitis: drug release study and antibacterial activity.
J Oral Biol Craniofac Res. 2019 Jul-Sep;9(3):190-200. doi: 10.1016/j.jobcr.2019.04.001. Epub 2019 Apr 12.

本文引用的文献

1
Development of satranidazole mucoadhesive gel for the treatment of periodontitis.
AAPS PharmSciTech. 2009;10(3):716-23. doi: 10.1208/s12249-009-9260-z. Epub 2009 May 29.
3
Prehospital intranasal midazolam for the treatment of pediatric seizures.
Pediatr Emerg Care. 2007 Mar;23(3):148-53. doi: 10.1097/PEC.0b013e3180328c92.
4
Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.
AAPS PharmSciTech. 2006 Aug 4;7(3):67. doi: 10.1208/pt070367.
5
Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer.
Int J Pharm. 2007 Feb 7;330(1-2):23-31. doi: 10.1016/j.ijpharm.2006.08.043. Epub 2006 Sep 1.
6
Intranasal midazolam vs rectal diazepam in acute childhood seizures.
Pediatr Neurol. 2006 May;34(5):355-9. doi: 10.1016/j.pediatrneurol.2005.09.006.
7
Intranasal midazolam therapy for pediatric status epilepticus.
Am J Emerg Med. 2006 May;24(3):343-6. doi: 10.1016/j.ajem.2005.11.004.
8
Nasal route and drug delivery systems.
Pharm World Sci. 2004 Jun;26(3):137-42. doi: 10.1023/b:phar.0000026823.82950.ff.
9
Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children.
Epilepsy Behav. 2004 Apr;5(2):253-5. doi: 10.1016/j.yebeh.2004.01.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验